Thryv Therapeutics

0 followers


Thryv Therapeutics is a genetic disorder that causes a prolongation between the beginning of the QRS complex and the end of the T waveQ and T waves on the EKG, indicating a prolongation of ventricular repolarization and the action potential duration. The lengthening of this complex is associated wit... Read more

Employees

1-10

Links

Org chart

Paul F. Truex
Chairman & CEO

Paul F. Truex

Collapse
Debra Odink
President & Chief Development Officer
Philip Sager
Chief Medical Officer
Aidan McNeil
Associate General Counsel & VP, Administration
Eric Campeau
VP, Translational Research
Curtis Mcgrath
Associate Director, Finance
Daphne Doucet
Manager, Corporate Communications

Board & advisors

Robert Booth
Director
Shi Yin Foo
Director
Daniel Hétu
Director
Scott Weiner
Director
Saumya Das
Board Observer
Marc-Olivier Sirard
Board Observer
Michael J Ackerman
Scientific Advisor
Stanley Nattel
Scientific Advisor
Anthony Rosenzweig
Scientific Advisor
Dinesh Srinivasan
Scientific Advisor
Arthur A.m. Wilde
Scientific Advisor